companydata.dkcompanydata.dk

PHARMCO I ApS: Financial statements 2022

CVR: 25204042

Source: annual report 2022, Danish Business Authority

01/01/2022 – 31/12/2022

PHARMCO I ApS (CVR 25204042) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -72,000 and a net result of DKK 17,542,000 compared with DKK 43,203,000 the year before. Equity in the 2022 report amounted to DKK 332,779,000. The solvency ratio was 98.9%. The company had 425 employees in the financial year.

Revenue
DKK 0
Gross Profit
DKK -72,000
Profit/Loss
DKK 17,542,000
Equity
DKK 332,779,000
Total Assets
DKK 336,643,000
Employees
425

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
20220-72 t.17.5 mio.332.8 mio.425
20210-69 t.43.2 mio.316.3 mio.420
20200-82 t.36.1 mio.272.5 mio.394
20190-66 t.31.6 mio.237.2 mio.375
20180-66 t.19.1 mio.190.7 mio.364

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on PHARMCO I ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

PHARMCO I ApS: The 2021 annual report is outJun 14, 2022

PHARMCO I ApS has published its annual report for 2021. Revenue came to DKK 0, and the net result was DKK 43,203,000.

About PHARMCO I ApS

PHARMCO I ApS is a Danish company of the type Anpartsselskab based in Vojens, founded in 2000. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Eli Wallin. The company is owned by Eli Wallin. According to the 2025 annual report, the company had an average of 473 employees. In 2025, the company reported a gross profit of DKK -105,000 and a net result of DKK 92,326,000 compared with DKK 44,804,000 the year before. Equity in the 2025 report amounted to DKK 469,411,000.

Source: annual report 2025, Danish Business Authority